HomeAbout The ConferenceInvitation To ILCA 2021

Invitation To ILCA 2021

Invitation To ILCA 2021

Our 2020 annual conference, ILCA Virtual 2020, was an incredible success, with over 4.4/5 of attendees ready to recommend the meeting. We’re back in September 2021 with a new week of learning to support the global liver cancer community.

Thanks once again to everyone who joined us in September 2020. Over 700 people came together to debate key topics in HCC and to learn from the best researchers and opinion leaders.

During the next ILCA Annual Conference, we’ll show you how to apply the latest insights and learnings for greatest impact. From Research to Application.

ILCA 2021 will be live on 2-5 September 2021 and is for everyone in the liver cancer community.

At ILCA 2021, you can expect a week of cutting-edge ideas and upskilling opportunities to drive patient care and to impact careers. You can expect practical insights, workshops, big idea presentations and, of course, exciting formats to encourage knowledge sharing and networking between physicians, researchers, and partners from all over the world.

Due to the ongoing COVID-19 pandemic, we are planning ILCA 2021 to be our second virtual conference. It is our great pleasure to invite you to attend the conference and to make together ILCA 2021 an overwhelming success!

Why Attend?

Exchange expertise across all liver cancer interrelated fields

Increase personal knowledge and best practices in basic and clinical research

Hear about the latest innovations and advancements in research and treatment levels

Take advantage of a multidisciplinary and international networking opportunity

Be inspired by an impressive speaker line-up of experts in liver cancer

Meet partners and learn the latest industry developments

A scientific programme presented in a diverse range of formats

Highlighted sessions and networking for students and young investigators

Who should attend?

ILCA 2021 will be the premier forum for clinical, translational and basic researchers and physicians, as well as allied professionals across liver cancer-related disciplines to share best practices and findings and advance research in the pathogenesis, prevention, and treatment of liver cancer.

Copyright © ILCA 2021